Vitamin D Regulates Steroidogenesis and Insulin-like Growth Factor Binding Protein-1 (IGFBP-1) Production in Human Ovarian Cells
min D on regulation of steroid hormone and IGFBP-1 production in human ovarian cell systems. We also examined whether Vitamin D and insulin interact in regulation of ovarian steroidogenesis and IGFBP-1 production. The institutional review boards at Beth Israel Medical Center and at the Weill Medical College of Cornell University approved all studies described in this report.
Methods

▼ Cell culture systems
Granulosa cells were obtained during in vitro fertilization over the course of 24 months and were pooled from several patients at a time to ensure adequate cell number for the experiments. The diagnoses included male factor, tubal factor and uterine factor infertility, endometriosis, and anovulation. For mixed ovarian cell culture containing granulosa, stromal and thecal cells, ovarian tissue samples were collected from 26 women at the time of indicated oophorectomy. The patients ' Introduction ▼ 1,25-(OH) 2 vitamin D is the active form of vitamin D. Although its primary role is to regulate calcium and phosphorus metabolism, recently many other actions of vitamin D have been identifi ed. Eff ects of vitamin D are mediated through vitamin D receptor, a member of nuclear receptor superfamily of ligand-activated transcription factors. Presence of vitamin D receptor in animal ovaries and its role in female reproduction in mice, rats, and Chinese hamster are documented in several studies [1 -5] . Although presence of vitamin D receptor in human ovary has been reported in one study [6] , this fi nding has not been confi rmed and the role of vitamin D, if any, in human ovarian function is not known. Previous studies have demonstrated that insulin upregulates steroidogenesis and inhibits IGFBP-1 production in granulosa cells. However, the interactions between vitamin D and insulin in the ovary have not been explored. The primary goals of this study were to confi rm the presence of vitamin D receptor in human ovarian cells and to examine the eff ects of vita- age ranged from 27 -50 years. Both culture systems are described in details in our previous publications [7, 8] . Both mixed ovarian cells and granulosa cells were incubated in M199 or MEM Eagle tissue culture medium supplemented with Fetal Bovine Serum (FBS) and steroid hormone substrates (30 μ M pregnenolone, or 30 μ M dehydroepiandrosterone, or 3 μ M testosterone, or 3 μ M androstenedione) with or without 1,25-(OH) 2 D 3 (50 pM -150 pM or 50 nM -150 nM) and with or without insulin (10, 10 2 , 10 3 ng / ml) [7, 8] . We used the active form of vitamin D, 1,25-(OH) 2 D 3 , to examine its eff ects on the steroid hormone and IGFBP-1 production in M199 tissue culture medium that contains vitamin D 2 , since we confi rmed that in our ovarian cell cultures, 1-α -hydroxylase expression was absent ( • ▶ Fig. 1 ).
Steroid hormone and IGFBP-1 production
During in vitro fertilization granulosa cells are exposed to high concentrations of gonadotropins and become highly luteinized. As a result, progesterone production in these cells is maximized and becomes supraphysiological. Therefore, progesterone experiments were carried out in mixed ovarian culture, which contains nonluteinized granulosa cells. Testosterone is produced in thecal and stromal cells, but not in granulosa cells. Hence, testosterone studies were carried out in mixed ovarian cell cultures. Estrogen is primarily synthesized in granulosa cells, which abundantly expresses aromatase enzyme that converts androgens to estrogen. Thus, estrogen studies were carried out in granulosa cells. Progesterone, testosterone and estradiol concentrations in the tissue culture medium were measured using radioimmunoassay (RIA). Estrone was measured using Enzyme Linked ImmunoSorbent Assay (ELISA).
IGFBP-1 concentration in tissue culture medium was measured using ELISA. Detectable amounts of IGFBP-1 were produced by the granulosa cells obtained during IVF. In our preliminary experiments, IGFBP-1 production in mixed ovarian cell culture was close to the lower limit of detection sensitivity in the available assay and the results, therefore, were highly variable. For this reason the IGFBP-1 studies were conducted in the granulosa cell cultures. Under our experimental conditions, IGF-I concentration in the conditioned tissue culture medium was negligible as all the experiments were carried out in IGF-I free media, with 0.1 % FBS being the only source of IGF-I.
Total RNA isolation and RT-PCR
Mixed ovarian cells or granulosa cells were incubated either in medium M199 or in vitamin D free MEM Eagle medium for total RNA isolation experiments. The total RNA was isolated using RNAqueous-4PCR kit according to the manufacturer ' s recommendations (Ambion Inc., Austin, Texas, USA). The concentration of RNA was determined by reading the absorbance in spectrophotometer at 260 and 280 nm. GeneAmp EZ rTth RNA PCR kit was used for RT-PCR reaction. Thermostable recombinant DNA polymerase was used as both a reverse transcriptase and as a DNA polymerase in a single PCR reaction. The vitamin D receptor forward primer was 5 ′ -GCC CAC CAT AAG ACC TAC GA-3 ′ and the reverse primer was 5 ′ -AGA TTG GAG AAG CTG GAC GA-3 ′ . β -Actin, house protein was used to demonstrate the relative abundance of mRNA under each set of conditions in mixed ovarian cell culture. β -Actin forward primer was 5 ′ -AAA CTG GAA CGG TGA AGG TG-3 ′ and reverse primer was 5 ′ -AGA GAA GTG GGG TGG TTT T-3 ′ . Because the granulosa cells are specialized cells, the expression of β -actin in these cells is not as abundant as in other types of ovarian cells. Therefore, in granulosa cell culture equal amount of total RNA was used to analyze relative abundance of 28 s rRNA and 18 s rRNA under each set of conditions suggested by the manufacturer (Ambion Inc., Austin, Texas, USA). RNA was quantifi ed by measuring optical density at 260 nm. An amount of 2 -3 μ g purifi ed total RNA, primer, deoxyribose nucleotides and rTth DNA polymerase were used in the concentrations suggested by the manufacturer for RT-PCR (Applied Biosystems, Branchburg, NJ, USA). The reverse transcription reaction was carried out at 65 ° C for 40 min and the PCR reaction was carried out in a 2-temperature PCR (94 ° C for 15 s followed by 62 ° C for 40 s) for 30 cycles (GeneAmp PCR system 9 700). To rule out genomic DNA contamination in the RNA preparation used for RT-PCR, the reverse transcription step was omitted in a separate sample (data not shown). The cDNA was separated on 2.5 % agarose gel in TBE buff er and was stained with 2 μ g / ml ethidium bromide to visualize DNA bands on a UV transilluminator. 
Materials
Statistical analysis
All experiments were carried out in quadruplicate. For hormone production experiments, Student t -test was used to compare mean values of each set of data. Pairwise t -test was used to compare mean values according to insulin concentrations in the presence or absence of 1,25-(OH) 2 D 3 . Because the eff ects of vitamin D on the mRNA expression and steroid hormone production were not dosedependent, data obtained from experiments with diff erent concentrations of vitamin D were pooled and then compared to control cell population. Since absolute concentrations of steroid hormones and IGFBP-1 in tissue culture medium at baseline diff ered among samples from diff erent patients, results were normalized to each sample ' s baseline level, which was considered 100 % . 
Results
▼ Vitamin D receptor in the human ovary
1,25-(OH) 2 D 3 eff ect on steroidogenesis
1,25-(OH) 2 D 3 increased progesterone production in mixed ovarian cell culture by 13 % compared to control (p < 0.001), but had no signifi cant eff ect on testosterone production ( • ▶ Fig. 2a ). 1,25-(OH) 2 D 3 stimulated estradiol or estrone production in purifi ed granulosa cell culture by up to 6 % (p < 0.02) and up to 21 % (p < 0.005) compared to control, respectively ( • ▶ Fig. 2b ).
Interaction of 1,25-(OH) 2 D 3 with insulin
In the granulosa cell culture, insulin stimulated estradiol production by 13 % (p < 0.04) ( • ▶ Fig. 2c ). 1,25-(OH) 2 D 3 acted synergistically with insulin to increase estradiol production by up to 50 % (p < 0.001) ( • ▶ Fig. 2c ). In contrast, insulin and 1,25-(OH) 2 D 3 had no signifi cant synergistic eff ect on progesterone, testosterone, or estrone production (data not shown). mutant mice, serum level of estrogens in these animals was signifi cantly lower than in heterozygous mice [3] , suggesting a role of vitamin D in estrogen synthesis. Presence of vitamin D receptor in human ovarian tissue was demonstrated in one study but has not been confi rmed [8] . eff ects on the steroid hormone production. These eff ects range between 10 -20 % and the corresponding eff ects on the steroidogenic enzyme mRNA expression, if any, may be too small to be detected in our experiments.
IGFBP-1 production
Our results also demonstrate that 1,25-(OH) 2 D 3 acted synergistically with insulin to stimulate estradiol production. Although the mechanism of this synergism remains unknown, increased insulin sensitivity in the presence of vitamin D has been described in the studies of glycemic control [10] . Therefore in the ovary, vitamin D may be acting as an insulin sensitizer. IGFBP-1 is one member of IGFBP family whose production is regulated by insulin. In vivo IGFBP-1 is produced in the liver, but also in other organs, including the ovary. IGFBP-1 production is regulated by insulin and IGF-I. We had previously demonstrated that in granulosa cells system, insulin and IGF-1 inhibit IGFBP-1 production, similar to their eff ects in the liver [7] . We examined IGFBP-1 production in the presence of vitamin D and insulin to determine whether, similar to its eff ect on steroidogenesis, vitamin D exerts insulin-sensitizing eff ect on IGFBP-1 production in human ovarian cells. Our studies demonstrated that vitamin D and insulin synergistically enhanced inhibition of IGFBP-1 production, although vitamin D, when used alone, stimulated IGFBP-1 production. In summary, vitamin D has both an independent and an insulin-sensitizing eff ect on IGFBP-1 production in human ovarian cells and these eff ects are opposite in direction. Mechanisms of this interesting phenomenon need to be investigated further. We conclude that vitamin D stimulates production of progesterone, estrone and estradiol in cultured human ovarian cells both independently and, in the case of estradiol, synergistically with insulin. Vitamin D also stimulates IGFBP-1 production when used alone. When used with insulin, however, vitamin D enhances insulin-induced inhibition of IGFBP-1 production in cultured human ovarian cells. Further studies are needed to determine the full range of vitamin D eff ects in the human ovary, their mechanisms and clinical signifi cance.
